Makes sense. For sure- we as humans are/should reasonably

New Post Public Reply Private Reply Replies (0) Message Board
CGC bwolfy2002 #83813
620
Makes sense. For sure- we as humans are/should reasonably be in a rush to provide each person with a vaccine to protect all of us- to mitigate mutations, deaths- major stuff.

I am finding that in many of the conversations this world is having (or needs to have and isn’t) a few things are missing: nuance and/or empathy. (Disclosure: So hopeful about Leronlimab, retired after years of public service- primarily public health- and eager for folks like my elderly mom to get ANY vaccine.)

Thinking (and in an internal conundrum) about . . .

- A public health system (thinking also about BP and the clinical trial process) historically focused on white men: ‘Diversity’ is a word giggled at by the public or a box checked. (ex., Tuskegee study- https://www.cdc.gov/tuskegee/timeline.htm ). I even see that here when in connection with the conversations about the board make-up.

- Individuals with medical issues: If pregnant, breastfeeding, have an over or under active immune system, COPD, obesity, etc. those folks would reasonably like to know more about what is best for them and if they have been included in any considerations.

- Options: Have loved ones in Africa. Are they getting what they need? Lived there many years- and have seen fist hand that the bottom of the barrel is provided there- ex. batteries that last 15 minutes, lack of health care, etc.

- Un/Reasonable questions: Folks I have talked to worry about the long-term effects of a vaccine, use of aborted fetus (not me- just relaying!), the rush because there is such a need, already had covid, etc.

- Data, Data!: After the 2013 government shutdown- there was a major shift in the public sector. We public servants started demanding that our ‘leaders’ start telling the public what we actually do (after seeing that they public pretty much only thought the government ran public parks). The pendulum shifted to data, data. I was thrilled at first- it would show what great things were happening- until the focus of public health shifted way too far to only data- versus services, better than SOC, etc. (“I don’t care how many babies are saved by the program- if we don’t have the date to show it.”) The recent AMA conference call nearly brought tears to my eyes hearing the same BS. (I believe someone on this board is very familiar with ‘using’ data . . . .)

- Total focus on vaccines versus therapeutics: Nuff said.

Sorry for the rant- but am feeling that I (i.e., public health) may have a part in putting people into a place of distrust. Breaks my heart. But to get through it we need to question and have discourse on the concerns. I – for one- so appreciate the information and expertise on the nuances.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 6

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

CTS Corporation's Q3 2024 Financial Performance Overview

Updated Category News Views 51

CTS Corporation Reports Improved Q3 2024 Results LISLE, Ill. — CTS Corporation (NYSE: CTS), a premier global designer and manufacturer of custom engineered solutions, has successfully recorded its third quarter results for 2024. Financial Highlights for Q3 2024 In the latest quarter, CTS highlighted several important financial metrics for investors: Sales amounted to...

Continue Reading
Adrian Cousins Steps Up as Head of London Market Claims at WTW

Updated Category News Views 154

Adrian Cousins Takes Lead Role at WTW WTW has recently announced the appointment of Adrian Cousins as the new Head of London Market Claims. This decision marks a significant step in the company's ongoing commitment to enhancing its claims strategy within the London market. Cousins, who has proven leadership skills and extensive experience in the industry, is set to take...

Continue Reading
Innovative Virtual Reality Solution for Remote Testing Licenses

Updated Category News Views 171

Revolutionizing Testing with Virtual Reality In today's fast-paced world, the need for innovative solutions has never been greater. One inventor from the heart of the United States has set out to address a significant challenge: testing for licenses and certifications. Introducing the C Z 2 O Z V R HUBS, an inventive virtual reality system designed for individuals seeking...

Continue Reading
New Edge Living Enhances CDA National Reserve with Luxurious Upgrades

Updated Category News Views 299

Transformative Enhancements at CDA National Reserve New Edge Living, a leader in innovative real estate development, has marked a significant evolution at CDA National Reserve, a premier private residential club that promises an exceptional blend of lifestyle and luxury. This sprawling 1,000-acre sporting and wellness destination aims to redefine the modern club...

Continue Reading
Kuros Biosciences Boosts Growth Forecast Amid Strong Sales Report

Updated Category News Views 211

Kuros Biosciences Enhances 2025 Growth Projections Kuros Biosciences, a frontrunner in the field of innovative biologic technologies, recently announced a remarkable financial performance. The company recorded a 77% increase in revenue for the first nine months of the year, solidifying its position in the market. Impressive Financial Results In just the first three...

Continue Reading